Mealey's (September 17, 2019, 1:49 PM EDT) -- WASHINGTON, D.C. — A decision by a Virginia federal judge to sustain the U.S. Patent and Trademark Office (PTO)’s calculation of a term adjustment for an immunosuppression therapy drug patent was not erroneous, a divided Federal Circuit U.S. Court of Appeals ruled Sept. 16 (Mayo Foundation For Medical Education and Research v. Andrei Iancu, No. 18-2031, Fed. Cir., 2019 U.S. App. LEXIS 27771)....